Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion
Authors
Keywords
-
Journal
mAbs
Volume 6, Issue 1, Pages 173-184
Publisher
Informa UK Limited
Online
2013-11-21
DOI
10.4161/mabs.26773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a Native Nanoelectrospray Mass Spectrometry Method for Determination of the Drug-to-Antibody Ratio of Antibody–Drug Conjugates
- (2013) Jia Chen et al. ANALYTICAL CHEMISTRY
- A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
- (2013) Scott C. Jeffrey et al. BIOCONJUGATE CHEMISTRY
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
- (2013) Pavel Strop et al. CHEMISTRY & BIOLOGY
- Analytical and bioanalytical technologies for characterizing antibody–drug conjugates
- (2013) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometry
- (2013) Heather Lynaugh et al. mAbs
- Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
- (2013) Daniel Ayoub et al. mAbs
- In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap
- (2013) Sara Rosati et al. mAbs
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Analytical characterization of biosimilar antibodies and Fc-fusion proteins
- (2013) Alain Beck et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Characterization of Therapeutic Antibodies and Related Products
- (2012) Alain Beck et al. ANALYTICAL CHEMISTRY
- Native Intact Mass Determination of Antibodies Conjugated with Monomethyl Auristatin E and F at Interchain Cysteine Residues
- (2012) John F. Valliere-Douglass et al. ANALYTICAL CHEMISTRY
- Profiling Antibody Drug Conjugate Positional Isomers: A System-of-Equations Approach
- (2012) Lan N. Le et al. ANALYTICAL CHEMISTRY
- Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates
- (2012) Diego A. Gianolio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Fourth World Antibody-Drug Conjugate Summit
- (2012) Alain Beck et al. mAbs
- Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates
- (2012) Mauro Acchione et al. mAbs
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
- (2012) J. Y. Axup et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry
- (2011) Guillaume Chevreux et al. ANALYTICAL BIOCHEMISTRY
- World Antibody Drug Conjugate Summit Europe
- (2011) Alain Beck et al. mAbs
- Analytical methods for physicochemical characterization of antibody drug conjugates
- (2011) Aditya Wakankar et al. mAbs
- Ranking the Susceptibility of Disulfide Bonds in Human IgG1 Antibodies by Reduction, Differential Alkylation, and LC−MS Analysis
- (2010) Hongcheng Liu et al. ANALYTICAL CHEMISTRY
- Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
- (2010) Teemu T. Junttila et al. BREAST CANCER RESEARCH AND TREATMENT
- Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
- (2008) Alain Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search